EcoDrugPlus

Proteasome Subunit Beta Type-9-Like

Ensembl ID : ENSECRG00000013994
Gene Symbol: LOC114669384
3 Cross references
213 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSECRG00000012410
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSECRG00000013798
Gene Symbol: LOC114666421
3 Cross references
211 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSECRG00000017536
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSECRG00000021873
Gene Symbol: PRKCD
3 Cross references
283 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSECRG00000017293
Gene Symbol: PRKCE
3 Cross references
348 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSECRG00000013999
Gene Symbol: PRKCH
3 Cross references
223 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSECRG00000022360
Gene Symbol: PRKCG
3 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSECRG00000006878
Gene Symbol: PRKCI
3 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSECRG00000010183
Gene Symbol: PRKCQ
3 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSECRG00000006433
Gene Symbol: PRKCZ
3 Cross references
205 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSECRG00000006128
Gene Symbol: PRKDC
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).